BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 671172)

  • 1. Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity.
    Green OC; Winter RJ; Kawahara FS; Phillips LS; Lewy PR; Hart RL; Pachman LM
    J Pediatr; 1978 Aug; 93(2):299-303. PubMed ID: 671172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
    Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of prednisolone in children with the nephrotic syndrome.
    Rostin M; Barthe P; Houin G; Alvinerie M; Bouissou F
    Pediatr Nephrol; 1990 Sep; 4(5):470-3. PubMed ID: 2242307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
    Gatti G; Perucca E; Frigo GM; Notarangelo LD; Barberis L; Martini A
    Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysis.
    Bergrem H
    Kidney Int; 1983 Jun; 23(6):876-81. PubMed ID: 6887699
    [No Abstract]   [Full Text] [Related]  

  • 7. Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability.
    Davis M; Williams R; Chakraborty J; English J; Marks V; Ideo G; Tempini S
    Br J Clin Pharmacol; 1978 Jun; 5(6):501-5. PubMed ID: 656293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisolone pulse therapy for childhood systemic lupus erythematosus with prominent dermatomyositis. A case report.
    Wollina U; Schreiber G
    Dermatologica; 1985; 171(1):45-8. PubMed ID: 4029461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Removal of prednisone and prednisolone during plasma exchange].
    Assogba U; Baumelou A; Pecquinot MA; Raymond F; Durande JP; Lenoir G; Rottembourg J
    Ann Med Interne (Paris); 1988; 139 Suppl 1():38-9. PubMed ID: 3247989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior subcapsular cataracts. Related to long-term corticosteroid treatment in children.
    Bihari M; Grossman BJ
    Am J Dis Child; 1968 Dec; 116(6):604-8. PubMed ID: 5697192
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacokinetics of plasma total and free prednisolone during an alternate-day regimen.
    Fuwa Y; Yasuda K; Adachi K; Goshima E; Yamakita N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1991 Jan; 67(1):8-22. PubMed ID: 2013347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
    Center SA; Randolph JF; Warner KL; Simpson KW; Rishniw M
    Res Vet Sci; 2013 Aug; 95(1):225-30. PubMed ID: 23473553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Trial of Dexamethasone Versus Prednisone for Children with Acute Asthma Exacerbations.
    Paniagua N; Lopez R; Muñoz N; Tames M; Mojica E; Arana-Arri E; Mintegi S; Benito J
    J Pediatr; 2017 Dec; 191():190-196.e1. PubMed ID: 29173304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of plasma prednisolone in man.
    Wilson CG; Ssendagire R; May CS; Paterson JW
    Br J Clin Pharmacol; 1975 Aug; 2(4):321-5. PubMed ID: 1233991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema.
    Lee DA; Taylor GM; James VH; Walker G
    Gut; 1979 May; 20(5):349-55. PubMed ID: 223947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisone and prednisolone bioavailability in renal transplant patients.
    Gambertoglio JG; Frey FJ; Holford NH; Birnbaum JL; Lizak PS; Vincenti F; Feduska NJ; Salvatierra O; Amend WJ
    Kidney Int; 1982 Apr; 21(4):621-6. PubMed ID: 7047863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of prednisone and prednisolone by plasma exchange.
    Stigelman WH; Henry DH; Talbert RL; Townsend RJ
    Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of linear growth of body height in children with nephrotic syndrome.
    Hung YT; Yang LY
    J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
    Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL
    Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.